<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02657265</url>
  </required_header>
  <id_info>
    <org_study_id>EU2014-09</org_study_id>
    <nct_id>NCT02657265</nct_id>
  </id_info>
  <brief_title>SpineJack® Versus Conservative Treatment Study</brief_title>
  <official_title>Prospective Multicenter Randomized Study Comparing Two Standard Treatments: SpineJack® System and Conservative Orthopedic Management in Acute Traumatic Vertebral Fractures Types A1 and A3.1 According to the Magerl Classification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vexim SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MedPass International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Vexim SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare two standard treatments in acute stable traumatic vertebral fractures
      (types A1 and A3.1 by Magerl Classification). The two treatments are as follows:

        1. SpineJack® system

        2. Conservative Orthopedic Management consisting of brace and pain medication.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      100 subjects (18 to 60 years old) will be enrolled (1:1) with one to two painful traumatic
      fractures, non-pathological (types A1 and A3.1 by Magerl Classification).

      Subjects will be followed at admission, procedure, discharge, 1 month, 3 months, 12 months
      and 24 months post Vertebral Compression Fracture (VCF) reduction procedure or the set-up of
      the brace.

      The estimated enrollment period is 12 months and each patient should perform a 24 months
      follow-up period. Therefore, the total study duration is estimated to be 36 months for the
      complete study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS</measure>
    <time_frame>Mean Visual Analogue Scale (VAS) back pain score: change from baseline to 12 months follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>Screening/baseline, immediat post-op, 1, 3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EQ-5D</measure>
    <time_frame>Screening/baseline, immediat post-op, 1, 3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kyphotic angle</measure>
    <time_frame>Screening/baseline, immediat post-op, 1, 3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional Kyphotic Angle,</measure>
    <time_frame>Screening/baseline, immediat post-op, 1, 3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of safety through evaluation of adverse events</measure>
    <time_frame>Screening/baseline, immediat post-op, 1, 3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs comparison of overall treatments</measure>
    <time_frame>Screening/baseline, immediat post-op, 1, 3, 12 and 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Spinal Fractures</condition>
  <condition>Vertebral Compression Fractures</condition>
  <condition>Back Injuries</condition>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>SpineJack® system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Spine fracture management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Surgical corset according to measurement's impression, rigid corset with sternal support</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SpineJack system</intervention_name>
    <description>Spine fracture management for traumatic vertebral compression fracture</description>
    <arm_group_label>SpineJack® system</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conservative management</intervention_name>
    <description>Surgical corset according to measurement's impression, rigid corset with sternal support</description>
    <arm_group_label>Conservative management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient must have signed the consent form

          2. Male or Female between 18 and 60 years old

          3. One to two painful traumatic fractures, non-pathological, traumatic vertebral fracture
             is less than 10 days, between T11 and L5, type A1 and A3.1 according to Magerl
             classification. All the fractures should meet the inclusion criteria (deformity,
             etiology, technical possibility of performing the procedure).

          4. Vertebral kyphosis angle &gt;10°

          5. Patient is eligible to treatment with brace

          6. Technical feasibility of a SpineJack® procedure and brace 1 to 5 days after
             screening/baseline

        Exclusion Criteria:

          1. Vertebral fracture more than 10 days old

          2. Spontaneous osteoporotic vertebral fracture

          3. Neurological signs or symptoms related to the vertebral fracture

          4. Vertebral kyphosis angle &gt;30°

          5. Active systemic or local infection at baseline

          6. Patient with substance abuse

          7. History of intolerance or allergic reaction to titanium or acrylic compounds

          8. Fracture geometry making the insertion of the implant impossible

          9. Malignant lesions

         10. Any other medical illness or condition that, in the investigator's opinion, is likely
             to impair long-term follow-up (e.g., cancer) or greatly increase the risk of surgery*

         11. Patient on long-term steroid therapy (steroid dose ≥ 30 mg /day for &gt; 3 months)

         12. Patient presenting with a non-correctable spontaneous or therapeutic coagulation
             disorder.

         13. Non-compliant patient: Impossibility to participate in the study and to be followed-up
             for 2 years.

         14. Participating in any other investigational study

         15. Female patients who are pregnant, breastfeeding, or planning to get pregnant during
             the course of the study

         16. Patient not affiliated to social security *: including but not limited to patients
             with contraindications for general anesthesia (surgeon expertise)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Pierre HONTAS</last_name>
    <role>Study Director</role>
    <affiliation>Vexim SA</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie-Pierre HONTAS</last_name>
    <phone>0033 6 69 71 55 23</phone>
    <email>mp.hontas@vexim.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>VEXIM SA</name>
      <address>
        <city>Balma</city>
        <zip>31130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean-Marc VITAL, Pr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier GILLE, Pr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ould Slimane Mourad, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lebhar Jonathan, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grelat Michael, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mortada Jihad, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Foulongne Emmanuel, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vasile Christian, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Alexandre, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Magro Elsa, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kaya Jean-Marc, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Touta Adamou, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petit Antoine, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Katranji Hassan, Dr</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2016</study_first_submitted>
  <study_first_submitted_qc>January 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2016</study_first_posted>
  <last_update_submitted>November 16, 2017</last_update_submitted>
  <last_update_submitted_qc>November 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Fractures, Compression</mesh_term>
    <mesh_term>Spinal Fractures</mesh_term>
    <mesh_term>Back Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

